Barrett Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-815
Closed -$81K 386
2019
Q3
$81K Sell
815
-500
-38% -$47.5K 0.01% 201
2019
Q2
$122K Sell
1,315
-47,667
-97% -$4.53M 0.01% 177
2019
Q1
$4.62M Sell
48,982
-59
-0.1% -$5.16K 0.31% 61
2018
Q4
$3.14M Sell
49,041
-17,585
-26% -$1.3M 0.24% 70
2018
Q3
$5.96M Sell
66,626
-595
-0.9% -$52.6K 0.39% 56
2018
Q2
$5.34M Sell
67,221
-31,400
-32% -$2.61M 0.36% 60
2018
Q1
$8.8M Sell
98,621
-12,215
-11% -$1.17M 0.63% 46
2017
Q4
$11.6M Sell
110,836
-3,030
-3% -$342K 0.81% 41
2017
Q3
$16.6M Buy
113,866
+3,115
+3% +$424K 1.21% 33
2017
Q2
$14.4M Buy
110,751
+2,600
+2% +$319K 1.09% 36
2017
Q1
$13.5M Buy
108,151
+2,630
+2% +$315K 1.07% 36
2016
Q4
$12.2M Sell
105,521
-703
-0.7% -$78.3K 1.01% 40
2016
Q3
$11.1M Sell
106,224
-2,381
-2% -$258K 0.93% 42
2016
Q2
$10.7M Buy
108,605
+6,525
+6% +$675K 0.93% 42
2016
Q1
$10.2M Buy
102,080
+4,345
+4% +$447K 0.88% 41
2015
Q4
$11.7M Buy
97,735
+1,315
+1% +$152K 1.02% 37
2015
Q3
$10.4M Sell
96,420
-1,895
-2% -$235K 0.95% 38
2015
Q2
$11.4M Buy
98,315
+10,646
+12% +$1.22M 0.94% 40
2015
Q1
$10.1M Buy
87,669
+935
+1% +$112K 0.84% 46
2014
Q4
$9.7M Buy
86,734
+600
+0.7% +$63.3K 0.76% 45
2014
Q3
$8.16M Buy
86,134
+4,550
+6% +$411K 0.66% 52
2014
Q2
$7.01M Buy
81,584
+2,210
+3% +$168K 0.57% 56
2014
Q1
$5.54M Buy
79,374
+5,354
+7% +$424K 0.48% 58
2013
Q4
$6.25M Buy
74,020
+2,850
+4% +$226K 0.55% 50
2013
Q3
$5.49M Buy
71,170
+10,520
+17% +$737K 0.53% 53
2013
Q2
$3.55M Buy
+60,650
New +$3.65M 0.36% 64

Other funds holding CELG

Barrett Asset Management's CELG Position: Q4 2019 in Review

Barrett Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 815 shares — an estimated $81K sold.

Barrett Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $16.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Barrett Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Barrett Asset Management sold 815 Celgene Corp shares in Q4 2019, an estimated $81K.
  • Barrett Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Barrett Asset Management's Celgene Corp position peaked at $16.6M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Barrett Asset Management's 13F filing for Q4 2019, filed 4 Feb 2020.